More at Irish Examiner.
Trinity College Dublin Prof Tim Foster and his group have been working on the mechanisms of the hospital-acquired superbug since the early 1990s with funding from the Health Research Board (HRB) and Wellcome trust. In 1994 they isolated a surface protein from the bacterium called clumping factor A (ClfA) that binds to a blood protein called fibrinogen, a key step of the infection process. ClfA has the potential to form the basis of a vaccine and in the project, It could also be used as a preventative measure – during emergency surgery for instance, when the patient is particularly vulnerable to infection," he pointed out.
